Media.Player

Diagnosis and prognosis of Neurological and psychiatric disorders

总结

The company is a medical device provider that designs, validates and operates first in class image analysis software as a service offered through its web-enabled DEMETRICS platform. Aimed to aid in the diagnosis and prognosis of specific neurological and psychiatric diseases, the company’s lead VOLUMETRICS service allows specialists to analyze magnetic resonance images in a convenient and cost effective manner. We have developed proprietary technology based on sophisticated image analysis procedures to detect and interpret patterns of brain changes in cerebral substructures that are characteristic of Alzheimers Disease (AD). The process entails analyses of neurological MRIs obtained from standard 1.5-3.0 Tesla scanners widely used in westernized radiological centers. After a patient's MRI is uploaded to the company’s secure servers, the MRI data are automatically analyzed by the VOLUMETRICS image processing algorithms and a report is generated and returned to the requesting physician with rapid turnaround. The report contains a unique statistical analysis of the patient's MRI and reported clinical data to aid clinicians in interpreting this data.
该公司是一家在医疗设备供应商，通过其网络平台DEMETRICS提供服务，其影像分析软件的设计、验证及运营均居于世界前沿。为帮助特殊神经和精神类疾病的诊断和预后，该公司领先的VOLUMETRICS 服务允许专家使用一种便捷且高性价比的方式分析核磁共振图像。该公司已开发出专利技术，基于复杂的图像分析程序来检测和解释同阿尔茨海默病（AD）相关的脑部子结构变化的模式。这个过程使用了西方化的辐射中心广泛使用的标准1.5-3.0特斯拉扫描仪的神经核磁共振图像分析。病人的核磁共振图像被上传到公司的 安全服务器后，MRI数据会被VOLUMETRICS 图像处理算法自动分析，并会自动生成报告并迅速传回给发出请求的医生。报告包括病人核磁共振数据的独特统计分析和有报道的临床资料以帮助临床医生理解该数据。Clinical Applications: Neurological and psychiatric disorders
临床应用: 神经和精神类疾病

技术应用

其他类

详细技术说明

Stage: Two issued U.S. patents protect this technology, and four additional submissions have been filed. The technology has been validated and FDA approved. They are seeking distribution opportunities.
阶段: 两项已发布的专利保护该技术，并已提出附加四项申请。该技术已通过验证及FDA批准，正在寻找分销合作

合作类型

技术售让

覆盖范围

生物技术/制药/医疗

商品和服务

医疗器械/医疗设备